Knockout Tested Rabbit Recombinant Monoclonal BRD2 antibody. Suitable for IP, WB and reacts with Human, Mouse samples. Cited in 1 publication. Immunogen corresponding to Synthetic Peptide within Human BRD2 aa 650-750.
pH: 7.8 - 8.6
Preservative: 0.09% Sodium azide
Constituents: 98% Borate buffered saline, 0.1% BSA
IP | WB | |
---|---|---|
Human | Tested | Tested |
Mouse | Expected | Tested |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info - | Notes Use 10μl/0.5mg lysate. |
Species | Dilution info | Notes |
---|---|---|
Species Mouse | Dilution info Use at an assay dependent concentration. | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse | Dilution info 1/1000 | Notes - |
Species Human | Dilution info 1/1000 | Notes - |
Select an associated product type
Chromatin reader protein that specifically recognizes and binds histone H4 acetylated at 'Lys-5' and 'Lys-12' (H4K5ac and H4K12ac, respectively), thereby controlling gene expression and remodeling chromatin structures (PubMed:17148447, PubMed:17848202, PubMed:18406326, PubMed:20048151, PubMed:20709061, PubMed:20871596). Recruits transcription factors and coactivators to target gene sites, and activates RNA polymerase II machinery for transcriptional elongation (PubMed:28262505). Plays a key role in genome compartmentalization via its association with CTCF and cohesin: recruited to chromatin by CTCF and promotes formation of topologically associating domains (TADs) via its ability to bind acetylated histones, contributing to CTCF boundary formation and enhancer insulation (PubMed:35410381). Also recognizes and binds acetylated non-histone proteins, such as STAT3 (PubMed:28262505). Involved in inflammatory response by regulating differentiation of naive CD4(+) T-cells into T-helper Th17: recognizes and binds STAT3 acetylated at 'Lys-87', promoting STAT3 recruitment to chromatin (PubMed:28262505). In addition to acetylated lysines, also recognizes and binds lysine residues on histones that are both methylated and acetylated on the same side chain to form N6-acetyl-N6-methyllysine (Kacme), an epigenetic mark of active chromatin associated with increased transcriptional initiation (PubMed:37731000). Specifically binds histone H4 acetyl-methylated at 'Lys-5' and 'Lys-12' (H4K5acme and H4K12acme, respectively) (PubMed:37731000).
KIAA9001, RING3, BRD2, Bromodomain-containing protein 2, O27.1.1
Knockout Tested Rabbit Recombinant Monoclonal BRD2 antibody. Suitable for IP, WB and reacts with Human, Mouse samples. Cited in 1 publication. Immunogen corresponding to Synthetic Peptide within Human BRD2 aa 650-750.
pH: 7.8 - 8.6
Preservative: 0.09% Sodium azide
Constituents: 98% Borate buffered saline, 0.1% BSA
Recombinant antibody was purified from cell culture supernatant.
This product is sold under License from Bethyl Laboratories, Inc.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
BRD2 was immunoprecipitated from 0.5 mg HEK-293T whole cell lysate with ab243865 at 10 µl per reaction Western blot was performed on the immunoprecipitate using ab243865 at 1/1000 dilution. Lane 1: ab243865 IP in HEK-293T cell lysate.
Lane 2: Contol IgG in HEK-293T cell lysate.
Detection: Chemiluminescence with an exposure time of 3 minutes.
All lanes: Immunoprecipitation - Anti-BRD2 antibody [BL-167-2A2] (ab243865)
Predicted band size: 88 kDa
ab243865 Anti-BRD2 antibody [BL-167-2A2] was shown to specifically react with BRD2 in wild-type HEK293T cells. Loss of signal was observed when knockout cell line Human BRD2 knockout HEK-293T cell line ab267265 (knockout cell lysate Human BRD2 knockout HEK-293T cell lysate ab257191) was used. Wild-type and BRD2 knockout samples were subjected to SDS-PAGE. ab243865 and Anti-GAPDH antibody [6C5] - Loading Control (Anti-GAPDH antibody [6C5] - Loading Control ab8245) were incubated at room temperature for 2. 5 hours at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes: Western blot - Anti-BRD2 antibody [BL-167-2A2] (ab243865) at 1/1000 dilution
Lane 1: Wild-type HEK293T cell lysate at 20 µg
Lane 2: BRD2 knockout HEK293T cell lysate at 20 µg
Lane 2: Western blot - Human BRD2 knockout HEK-293T cell line (Human BRD2 knockout HEK-293T cell line ab267265)
Lane 3: HeLa cell lysate at 20 µg
All lanes: Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed ab216773) at 1/10000 dilution
Predicted band size: 88 kDa
Observed band size: 110 kDa
All lanes: Western blot - Anti-BRD2 antibody [BL-167-2A2] (ab243865) at 1/1000 dilution
Lane 1: HEK-293T (Human epithelial cell line from embryonic kidney transformed with large T antigen) whole cell lysate at 50 µg
Lane 2: MCF7 (Human breast adenocarcinoma cell line) whole cell lysate at 50 µg
Lane 3: Hep G2 (Human liver hepatocellular carcinoma cell line) whole cell lysate at 50 µg
Lane 4: A549 (Human lung carcinoma cell line) whole cell lysate at 50 µg
Lane 5: SW620 (Human colon carcinoma cell line) whole cell lysate at 50 µg
Lane 6: SK-MEL-28 (Human melanoma cell line) whole cell lysate at 50 µg
Lane 7: Jurkat (Human T cell leukemia cell line from peripheral blood) whole cell lysate at 50 µg
All lanes: Goat anti-rabbit IgG, HRP conjugated
Predicted band size: 88 kDa
Exposure time: 30s
All lanes: Western blot - Anti-BRD2 antibody [BL-167-2A2] (ab243865) at 1/1000 dilution
Lane 1: RenCa (Mouse epithelial kidney cell line) whole cell lysate at 50 µg
Lane 2: NIH/3T3 (Mouse embryonic fibroblast cell line) whole cell lysate at 50 µg
Lane 3: C2C12 (Mouse myoblast cell line) whole cell lysate at 50 µg
All lanes: Goat anti-rabbit IgG, HRP conjugated
Predicted band size: 88 kDa
Exposure time: 3s
False colour image of Western blot: Anti-BRD2 antibody [BL-167-2A2] staining at 1/1000 dilution, shown in green; Mouse Anti-Nucleophosmin antibody [FC82291] (Anti-Nucleophosmin antibody [FC82291] ab10530) loading control staining at 2 ug/mL imaged in ECL. In Western blot, ab243865 was shown to bind specifically to BRD2. A band was observed at 110 kDa in wild-type A549 cell lysates with no signal observed at this size in BRD2 knockout cell line. To generate this image, wild-type and BRD2 knockout A549 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3% milk in TBS-0.1% Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4°C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times before development with Optiblot (ECL reagent Anti-PKC delta (phospho S299) antibody [EPNCI119] ab133456) and imaged with 20 seconds exposure time. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and HRP conjugated Goat anti-Mouse (H+L) at 1/20000 dilution.
All lanes: Western blot - Anti-BRD2 antibody [BL-167-2A2] (ab243865) at 1/1000 dilution
Lane 1: Wild-type A549 cytoplasm cell lysate at 20 µg
Lane 2: Wild-type A549 nuclear cell lysate at 20 µg
Lane 3: BRD2 knockout A549 C7 cytoplasm cell lysate at 20 µg
Lane 4: BRD2 knockout A549 C7 nuclear cell lysate at 20 µg
Lane 5: Wild-type HEK-293T cell lysate at 20 µg
Lane 6: BRD2 knockout HEK-293T cell lysate at 20 µg
Performed under reducing conditions.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com